Oligodendroglioma.
Van den Bent MJ, Reni M, Gatta G, Vecht C.
Crit Rev Oncol Hematol. 2008 Jun;66(3):262-72. doi: 10.1016/j.critrevonc.2007.11.007. Epub 2008 Feb 12.
Oligodendroglioma: a neurological perspective in Sub-saharan Africa.
James E, Okon II, Akpan U, Abigail O.
Neurosurg Rev. 2024 Jul 13;47(1):321. doi: 10.1007/s10143-024-02579-7.
Oligodendroglioma: pathology, molecular mechanisms and markers.
Wesseling P, van den Bent M, Perry A.
Acta Neuropathol. 2015 Jun;129(6):809-27. doi: 10.1007/s00401-015-1424-1. Epub 2015 May 6.
Metastatic anaplastic oligodendroglioma.
Macdonald DR, O'Brien RA, Gilbert JJ, Cairncross JG.
Neurology. 1989 Dec;39(12):1593-6. doi: 10.1212/wnl.39.12.1593.
Anaplastic oligodendroglioma metastasizing to the bone marrow: a unique case report and literature review.
Singh VK, Singh S, Bhupalam L.
Int J Neurosci. 2019 Jul;129(7):722-728. doi: 10.1080/00207454.2018.1557165. Epub 2019 Feb 13.
[Oligodendroglioma, IDH Mutation and 1p/19q Codeletion].
Matsutani T.
No Shinkei Geka. 2023 Sep;51(5):811-820. doi: 10.11477/mf.1436204822.
Papilloedema secondary to oligodendroglioma.
Roncone DP.
Clin Exp Optom. 2016 Nov;99(6):507-517. doi: 10.1111/cxo.12416. Epub 2016 Aug 3.
Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG, Macdonald DR, Ramsay DA.
Neurosurgery. 1992 Jul;31(1):78-82. doi: 10.1227/00006123-199207000-00011.
Treatment of oligodendroglioma: an update.
Paleologos NA, Cairncross JG.
Neuro Oncol. 1999 Jan;1(1):61-8.
Multiple oligodendroglioma--case report.
Ogasawara H, Kiya K, Uozumi T, Sugiyama K, Kawamoto K, Ohta M.
Neurol Med Chir (Tokyo). 1990 Feb;30(2):127-31. doi: 10.2176/nmc.30.127.
